News

Integration update on BI’s acquisition of Merial

Boehringer Ingelheim’s (BI) acquisition of Sanofi’s animal health business – Merial – has closed.  The acquisition makes BI the second largest animal health company in the world.

Steve Boren, VP of sales marketing for BI’s cattle business says the acquisition opens opportunity for research and development.  He says they are making significant investments in preventative care.

AUDIO: Steve Boren, Boehringer Ingelheim

Dan Harter, executive director of US ruminant and equine business for Merial says the acquisition provides a great opportunity for livestock producers as more money will be invested in research and development.

AUDIO: Dan Harter, Merial

Email this to someoneShare on FacebookTweet about this on TwitterShare on Google+Print this page

Add Comment

Your email address will not be published.


 

stay up to date

Subscribe for our newsletter today and receive relevant news straight to your inbox!